The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review

The introduction of immune checkpoint inhibitors (ICI), as a novel treatment modality, has transformed the field of oncology with unprecedented successes. However, the efficacy of ICI for patients with glioblastoma or brain metastases (BMs) from any tumor type is under debate. Therefore, we systemat...

Descripción completa

Detalles Bibliográficos
Autores principales: Brahm, Cyrillo G., van Linde, Myra E., Enting, Roelien H., Schuur, Maaike, Otten, René H.J., Heymans, Martijn W., Verheul, Henk M.W., Walenkamp, Annemiek M.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139638/
https://www.ncbi.nlm.nih.gov/pubmed/32143288
http://dx.doi.org/10.3390/cancers12030586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139638/
https://www.ncbi.nlm.nih.gov/pubmed/32143288
http://dx.doi.org/10.3390/cancers12030586

Ejemplares similares